This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
DXCM Secures Health Canada Authorization for Dexcom G7 15 Day CGM
by Zacks Equity Research
DexCom's G7 15 Day wins Health Canada authorization, offering longer wear, high accuracy and smart features for adults with diabetes.
DXCMPositive Net Change ISRGPositive Net Change CAHPositive Net Change WSTNegative Net Change
medical medical-devices
Do Options Traders Know Something About GE HealthCare Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to GEHC stock based on the movements in the options market lately.
GEHCNegative Net Change
medical medical-devices
Newsmax (NMAX) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
NMAXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Intuitive Surgical Pre-Q2 Analysis: Buy, Hold or Sell the Stock Now?
by Indrajit Bandyopadhyay
Intuitive Surgical heads into Q2 earnings with strong procedure momentum, da Vinci 5 adoption and expectations for another earnings beat despite margin pressures.
ISRGPositive Net Change BSXPositive Net Change TMONegative Net Change
medical medical-devices
Abbott's Q2 Earnings on Deck: How Should You Play the Stock Now?
by Moumi Mondal
ABT heads into Q2 earnings results with growth expected across Diagnostics, Devices and EPD, while Nutrition remains a drag. Here's what could shape the results.
ABTPositive Net Change DGXNegative Net Change TMONegative Net Change
earnings medical medical-devices
Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H
by Nalak Das
ISRG, IDXX and ALC are three AI-driven medical device laggards with strong business momentum and improving earnings estimates for a potential 2H rebound.
ISRGPositive Net Change ALCPositive Net Change IDXXPositive Net Change
medical-devices
Is Johnson & Johnson Stock Poised for New Highs as Q2 Results Approach?
by Shaun Pruitt
After hitting fresh all-time highs last week, investors are turning their attention to JNJ's Q2 report, which is scheduled for Wednesday, July 15, before the opening bell.
JNJPositive Net Change
dividend-investing dividends earnings investing large-cap medical medical-devices oncology-screening pharmaceuticals
5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds
by Indrajit Bandyopadhyay
Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positioned to generate wealth for investors amid improving industry prospect.
MCKPositive Net Change ALGNNegative Net Change CAHPositive Net Change HSICPositive Net Change WSTNegative Net Change
medical medical-devices
Alcon & RxSight Collaborate to Develop Adjustable PCIOL Technology
by Zacks Equity Research
ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surgery light adjustment.
ALCPositive Net Change WSTNegative Net Change VCYTNegative Net Change RXSTNegative Net Change
medical medical-devices
Top China Tech Plays Worth Adding to Your Portfolio in 2H26
by Vasundhara Sawalka
NetEase and peers gain appeal as U.S.-China trade easing and policy shifts lift confidence in Chinese tech into 2H26.
NTESNegative Net Change TSMNegative Net Change GDSNegative Net Change KCNegative Net Change
artificial-intelligence china cloud-computing electric-vehicles medical-devices robotics semiconductor tech-stocks thematic